Phase I–II study of lenalidomide and alemtuzumab in...

Cancer Immunology, Immunotherapy 2017 / 1 Vol. 66; Iss. 1

Phase I–II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints

Winqvist, Maria, Mozaffari, Fariba, Palma, Marzia, Eketorp Sylvan, Sandra, Hansson, Lotta, Mellstedt, Håkan, Österborg, Anders, Lundin, Jeanette
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
66
Language:
english
Journal:
Cancer Immunology, Immunotherapy
DOI:
10.1007/s00262-016-1922-6
Date:
January, 2017
File:
PDF, 742 KB
english, 2017
Conversion to is in progress
Conversion to is failed